Israel's Vacciguard introduces a unique biotech system to develop immunizations against some of the world's deadliest maladies, from cancer to CMV, and West Nile virus.
The notion of a vaccine for cancer - or for many other deadly diseases nearly impossible to control, let alone cure - may seem to be no more than wishful thinking. But that is exactly what Israeli biomed startup Vacciguard is introducing: A technology tool for developing vaccines against a wide range of diseases from cancer to West Nile virus.
We may be in the 21st century, says Vacciguard CEO Dr. Anat Eitan, but more than 15 million people die each year from infectious diseases - and not only in developing countries.
"Our technology consists of proprietary peptide carriers which are derived from a protein element called Heat Shock Protein 60 enabling a much more effective method of battling bacteria and viruses," says Eitan.